Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Armour Residential REIT Approaches Key Dividend Date Amid Mixed Performance

Andreas Sommer by Andreas Sommer
September 15, 2025
in Dividends, Real Estate & REITs
0
Armour Residential Reit Stock
0
SHARES
160
VIEWS
Share on FacebookShare on Twitter

Today marks a significant date for shareholders of Armour Residential REIT, as the company reaches its ex-dividend cutoff. Investors holding the stock through market close will qualify for the September distribution of $0.24 per share, scheduled for payment on September 29.

Financial Performance and Market Activity

The REIT’s recent trading activity reflects ongoing market volatility. While shares recorded a modest gain of 0.52 percent to close at $15.32 on Friday, some trading reports indicated a slight pullback to $15.26 just before the session ended, highlighting the stock’s unpredictable movements.

In its monthly operational update released on September 12, Armour Residential disclosed several key financial metrics:
* Debt-to-Equity Ratio: 7.4
* Implied Leverage: 7.8
* Total Liquidity: $1,089.4 million

Quarterly Results and Capital Activities

The company’s second-quarter fundamentals revealed continued challenges. Armour posted a GAAP net loss of $78.6 million, or $0.94 per share, falling substantially short of analyst expectations. Despite this bottom-line disappointment, the REIT generated distributable earnings of $64.9 million, equating to $0.77 per share. The book value per share also declined, dropping to $16.90 from $18.59 previously.

Should investors sell immediately? Or is it worth buying Armour Residential Reit?

On a more positive note, the company successfully raised $104.6 million in new capital through an at-the-market offering program, issuing 6.3 million additional shares.

Analyst Perspective and Strategic Focus

Market experts maintain a cautious outlook on Armour Residential REIT. The consensus rating currently stands at “Hold” with a price target of $15.50. The stock’s high beta of 1.38 continues to signal above-average volatility compared to the broader market. The company’s investment strategy remains centered on Agency Mortgage-Backed Securities, employing hedging techniques to mitigate interest rate risk.

The central question for investors remains whether the attractive dividend yield can sufficiently offset the company’s underlying fundamental weaknesses over the long term.

Ad

Armour Residential Reit Stock: Buy or Sell?! New Armour Residential Reit Analysis from February 7 delivers the answer:

The latest Armour Residential Reit figures speak for themselves: Urgent action needed for Armour Residential Reit investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Armour Residential Reit: Buy or sell? Read more here...

Tags: Armour Residential Reit
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Blue Ridge Bankshares Stock
Banking & Insurance

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

February 7, 2026
Claros Mortgage Trust Stock
Analysis

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

February 7, 2026
FRP Stock
Analysis

FRP Holdings: Annual Report to Provide Insight on Key Market Trends

February 7, 2026
Next Post
Microvast Holdings Stock

Microvast Stock Surges on Strong Quarterly Performance and Expansion Plans

Barrick Gold Stock

Barrick Gold Exits Canadian Operations with Major Mine Divestiture

Super Micro Computer Stock

Super Micro Stock Surges on Key AI Chip Deployment Milestone

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com